Editorial Policies
IJCY maintains clear editorial policies to protect research integrity, ensure fair review, and support ethical publication practices.
Policies apply to all submissions and are designed to align with international publishing standards.
Why Researchers Trust Us
Fast Publication
Average 4 weeks to first decision, 3 weeks to publication after acceptance
Expert Review
35+ editorial board members specializing in cytokine biology and immunology
Global Reach
Research disseminated to immunology professionals in 45+ countries immediately
Rigorous Standards
Double-blind peer review ensuring highest scientific quality and reproducibility
Journal at a Glance
International Journal of Cytokine publishes research that advances understanding of immune signaling, inflammation, and translational immunology. The journal emphasizes rigorous methodology, clear reporting, and clinical relevance to support evidence based care.
Our publishing model combines rapid editorial triage with expert peer review so that cytokine research can move from discovery to application efficiently.
- Peer reviewed open access journal focused on cytokine science.
- Double blind peer review and structured editorial decisions.
- DOI assignment and metadata delivery for discoverability.
- Global readership across immunology and clinical communities.
Quality and Transparency Commitment
Quality assurance is embedded throughout the IJCY workflow. Editorial screening, ethical checks, and reviewer guidance ensure that published results are credible, reproducible, and clinically meaningful.
Authors receive clear decision letters and detailed revision guidance, helping them improve manuscripts and communicate findings with precision.
- Structured reviewer criteria and decision templates.
- Integrity checks for originality and data clarity.
- Transparent timelines and consistent communication.
Editorial Independence
Editorial decisions are based solely on scientific quality, scope, and ethical compliance. Commercial interests do not influence acceptance decisions.
Editors follow standardized criteria to ensure consistent outcomes.
Peer Review Model
IJCY uses structured peer review with expert reviewers to evaluate originality, methodological rigor, and clinical relevance.
- Initial screening for scope and quality.
- Double blind peer review for unbiased assessment.
- Clear decision letters with revision guidance.
Review Timelines and Transparency
IJCY communicates expected timelines so authors can plan around grants and clinical schedules. Editors and reviewers are encouraged to provide timely feedback and clear decision rationales.
If delays occur, authors are updated promptly to maintain trust and transparency.
Clear timelines help authors coordinate revisions and funding reports.
We aim for predictable review cycles.
Ethics and Integrity
All submissions must meet ethical standards for human and animal research. Plagiarism screening and image integrity checks are performed on all manuscripts.
- Ethics approval and informed consent required.
- Conflict of interest and funding disclosures required.
- Authorship contributions must be stated clearly.
Authorship and Contributor Roles
IJCY follows clear authorship criteria to ensure accountability. All listed authors should have contributed substantially to study design, data generation, analysis, or interpretation.
Provide a contribution statement and disclose any editorial or medical writing assistance.
- Confirm all authors approve the final submission.
- List funding sources and institutional support.
- Disclose any conflicts of interest.
Corrections and Retractions
If errors are identified after publication, IJCY issues corrections or retractions according to established publication ethics guidance. Authors are expected to cooperate with investigations.
Transparent notices protect the integrity of the research record.
Post Publication Discussion
Scholarly discussion after publication is encouraged when evidence based and constructive. Readers may submit comments or clarifications, and authors are invited to respond when appropriate.
If substantial concerns are identified, the editorial office will evaluate and take appropriate action.
This process supports transparency while maintaining editorial oversight.
Appeals and Complaints
Authors may appeal decisions by providing clear responses to reviewer concerns. Appeals are evaluated by a senior editor not involved in the original decision.
Complaints related to ethics or reviewer conduct are handled confidentially with documented outcomes.
Appeals should be submitted promptly to keep timelines on track.
Clear appeals help resolve issues quickly.
Data and Reporting Standards
Transparent reporting improves reproducibility and supports evidence based practice. Clinical trials should include registration details and systematic reviews should document search strategies and inclusion criteria.
Authors should provide data availability statements and describe limitations clearly.
Complete reporting supports translation of cytokine findings into clinical settings.
Clear reporting also improves indexing accuracy.
Data and Reporting
IJCY requires complete reporting of methods, data availability, and study limitations. Clinical trials should include registration details and systematic reviews should report search strategies.
Transparent reporting improves reproducibility and supports evidence based practice.
Policy Questions
Editorial Policy Support
Contact the editorial office for policy clarification or ethics guidance.
[email protected]
